| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |